Quanterix Corporation

NASDAQ:QTRX

Medical - Devices

Healthcare
$2.07 +15.80%

+$0.46 today

Market cap
$98.28M
Beta
1.12
P/E (TTM)
-1.5
EPS (TTM)
-$2.22
52W Low $2.40High $8.77

Volume 3.54M

Average 1.15M

QTRX Operating Cash Flow

Cash generated by the company's core business operations during the period.

Quanterix CorporationNASDAQ: QTRX

Operating Cash Flow · Q1 FY2026 · quarter ended Mar 2026

Operating cash flow grows, but more slowly than its trailing trend

Q1 FY2026 operating cash flow of $18.11M (cash outflow) rose 30.4% year over year, behind the +182.0% change in trailing-twelve-month operating cash flow. Sequentially, it rose 10.1% from the prior quarter. Over 3 fiscal years it compounded at +17.0% a year.

Context

  • Operating cash flow amounted to 55.7% of revenue in FY2025, up 29.7 pp from a year earlier.
  • Operating cash flow grew in size in 2 of the last 3 fiscal years.
  • FY2025 was the largest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +30.4% toward the trailing-twelve-month pace of +182.0%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$18.11M+10.1% QoQ
Last fiscal yearDec 2025
-$77.24M+119.6% YoY
LTMMar 2026
-$81.46M+182.0% YoY
Operating Cash Flow past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+30.4%——
1 year+119.6%——
3-year CAGR+17.0%——
5-year CAGR——
10-year CAGR——

Operating Cash Flow history

USD · from the cash flow

Latest · FY2025
(77.24M) USD
Year-over-year change
-119.6%

Operating Cash Flow vs competitors

How QTRX compares with its peers on the latest reported figures

  • QTRX's LTM Mar 2026 operating cash flow of $81.46M is the largest of the 11 companies compared; the peer median is $29.31M.
  • Its year-over-year change of +182.0% is the 2nd highest of 11, against a peer median of +0.2%.
  • Operating cash flow amounts to 56.2% of revenue for QTRX, versus a peer median of 28.5%.
QTRX Competitors Peer median
Operating Cash Flow for QTRX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
QTRXQuanterix CorporationLTM Mar 2026$81.46M +182.0%+17.0%56.2%
SENSSenseonics Holdings, Inc.LTM Mar 2026$75.07M +33.4%-3.7%184.4%
VMDViemed Healthcare, Inc.LTM Mar 2026$57.13M +40.1%+23.2%19.9%
IMRXImmuneering CorporationLTM Mar 2026$49.7M -7.3%+0.9%—
NNOXNano-X Imaging Ltd.LTM Dec 2025$43.17M +18.0%-2.0%331.6%
CVRXCVRx, Inc.LTM Mar 2026$39.57M -3.5%-2.0%67.0%
OMOutset Medical, Inc.LTM Mar 2026$33.51M -65.1%-31.8%28.5%
SGHTSight Sciences, Inc.LTM Mar 2026$25.12M +3.9%-26.9%31.6%
MASS908 Devices Inc.LTM Mar 2026$7.59M -78.9%+4.2%13.1%
SNWVSANUWAVE Health, Inc.LTM Mar 2026$5.79M +3674.1%—13.1%
INGNInogen, Inc.LTM Mar 2026$1.11M -81.9%-33.1%0.3%
Peer median (excluding QTRX) $29.31M+0.2%-2.0%28.5%

Competitors are the stored peer set for QTRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(57.69M)(96.7M)(32.33M)(38.53M)(107.15M)
Depreciation & Amortization4.85M5.35M8.38M8.36M18.93M
Deferred Income Tax801K(226K)00(5.87M)
Stock-Based Compensation15.98M15.44M16.76M19.99M20.72M
Change in Working Capital(12.19M)2.07M(11.8M)(18.79M)(2.35M)
Accounts Receivables(6.85M)5.16M(6.7M)(7.7M)10.61M
Inventory(8.09M)5.39M(5.36M)(6.68M)4.03M
Accounts Payables2.41M(5.36M)1.19M723K(528K)
Other Working Capital343K(3.11M)(933K)(5.13M)(16.47M)
Other Non-Cash Items340K25.79M92K(6.19M)(1.51M)
Operating Cash Flow(47.91M)(48.27M)(18.9M)(35.16M)(77.24M)
Capital Expenditures(13.62M)(11.73M)(3.79M)(3.37M)(2.61M)
Acquisitions (Net)0000(93.23M)
Purchases of Investments00(175.61M)(295.61M)(69.76M)
Sales of Investments0031M216.71M215.83M
Other Investing Activities7.28M520K000
Investing Cash Flow(6.34M)(11.21M)(148.4M)(82.27M)50.23M
Debt Repayment(7.74M)0000
Common Stock Issued269.72M2.31M2.89M3.07M738K
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities8.82M0(198K)(2.61M)(1.45M)
Financing Cash Flow270.8M2.31M2.69M456K(708K)
Effect of Forex Changes(92K)(538K)301K(734K)1.57M
Net Change in Cash216.46M(57.71M)(164.31M)(117.71M)(26.14M)
Free Cash Flow(61.52M)(60M)(22.69M)(38.53M)(79.85M)

Quanterix Corporation

NASDAQ:QTRX

Intrinsic Alpha fair value

Locked

Current Price

$2.07

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.